News
RELAZA2: MRD-guided azacitidine reduces relapse risk in MDS and AML
MRD-guided azacitidine therapy reduces hematological relapse in patients with MDS or AML at high risk for relapse, according to RELAZA2 trial...
News
Predicting response to AZA in MDS, CMML
Researchers have developed a technique that may help predict whether patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic...
News
Right-sided CRC has poorer disease-free survival after adjuvant chemo
SAN FRANCISCO – “It’s becoming clear that right-sided tumors are different from left-sided tumors.”
News
Arthritis treatment costs per person held steady from 2008 to 2014
But why did it cost $60 billion more in aggregate treatment costs in 2014?
News
Meta-analysis: Lifestyle changes improve psoriasis
GENEVA – Obese patients can reduce psoriasis severity and boost quality of life with diet or exercise.
News
Do not delay tranexamic acid for hemorrhage
Immediate treatment improved survival by more than 70%, but the survival benefit decreased by 10% for every 15 minutes of treatment delay until...
News
Social media, apps aid adolescents, young adults with cancer
Stupid Cancer is a new app designed to connect adolescents and young adults who have cancer with each other and with resources and information.
News
Written exposure therapy rivals cognitive processing therapy for PTSD
Cognitive processing therapy might offer a greater benefit over time, but writing therapy offers a viable treatment in fewer sessions.
News
Gonadotropins succeed where clomifene fails
Live births are significantly more likely among women who take gonadotropins, whether accompanied by intercourse or intrauterine insemination.
News
CHIP out of cash amid government shutdown
Congress, President bicker while 9 million children lose insurance coverage.